Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

A volumetric analysis of timing and duration of T2/FLAIR changes on MRI following radiation therapy in patients with low-grade IDH-mutant glioma

View through CrossRef
Abstract Background Patients with IDH-mutant low-grade glioma (LGG) can achieve many years of survival with radiation (RT) and chemotherapy. There is a risk of overtreatment and negative treatment side effects if these patients are unnecessarily retreated due to perceived tumor progression in the absence of true tumor regrowth. A better understanding of volumetric postradiation FLAIR changes will help with the clinical interpretation of disease progression/treatment effect and will help guide management decisions. We conducted this research to characterize the changes in MRI FLAIR hyperintensity that occur in LGG patients following RT, to better understand the radiation-treatment effects or “pseudoprogression” that occurs in the absence of true tumor regrowth. Methods Serial MRI scans of patients with LGG were reviewed, including pre-RT and for 2.5 years post-RT. Segmentation for volumetric analysis was performed with manual supervision using ITK-SNAP (open-source segmentation software). Descriptive statistics are reported. Results Sixteen patients with histologic grade 2 gliomas were included. 159 MRI scans were segmented using ITK-SNAP (median 9.5 MRIs/patient). Nine of 16 MRIs showed decreasing FLAIR volume immediately post-RT, while 7/16 showed increasing FLAIR volume. After the initial post-RT MRI, 12/16 patients had MRIs with an increase in FLAIR volume sometime during the first year. The FLAIR volume stabilized or decreased a median of 18.4 months and a mean of 15.0 months post-RT. Conclusions FLAIR hyperintensity changes on MRI are highly variable in the first 1.5 years post-RT in low-grade glioma, but after 1.5 years, FLAIR volumes stabilize and decrease, likely indicating the inflection point where post-RT pseudoprogression stabilizes.
Title: A volumetric analysis of timing and duration of T2/FLAIR changes on MRI following radiation therapy in patients with low-grade IDH-mutant glioma
Description:
Abstract Background Patients with IDH-mutant low-grade glioma (LGG) can achieve many years of survival with radiation (RT) and chemotherapy.
There is a risk of overtreatment and negative treatment side effects if these patients are unnecessarily retreated due to perceived tumor progression in the absence of true tumor regrowth.
A better understanding of volumetric postradiation FLAIR changes will help with the clinical interpretation of disease progression/treatment effect and will help guide management decisions.
We conducted this research to characterize the changes in MRI FLAIR hyperintensity that occur in LGG patients following RT, to better understand the radiation-treatment effects or “pseudoprogression” that occurs in the absence of true tumor regrowth.
Methods Serial MRI scans of patients with LGG were reviewed, including pre-RT and for 2.
5 years post-RT.
Segmentation for volumetric analysis was performed with manual supervision using ITK-SNAP (open-source segmentation software).
Descriptive statistics are reported.
Results Sixteen patients with histologic grade 2 gliomas were included.
159 MRI scans were segmented using ITK-SNAP (median 9.
5 MRIs/patient).
Nine of 16 MRIs showed decreasing FLAIR volume immediately post-RT, while 7/16 showed increasing FLAIR volume.
After the initial post-RT MRI, 12/16 patients had MRIs with an increase in FLAIR volume sometime during the first year.
The FLAIR volume stabilized or decreased a median of 18.
4 months and a mean of 15.
0 months post-RT.
Conclusions FLAIR hyperintensity changes on MRI are highly variable in the first 1.
5 years post-RT in low-grade glioma, but after 1.
5 years, FLAIR volumes stabilize and decrease, likely indicating the inflection point where post-RT pseudoprogression stabilizes.

Related Results

Hydatid Disease of The Brain Parenchyma: A Systematic Review
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Abstarct Introduction Isolated brain hydatid disease (BHD) is an extremely rare form of echinococcosis. A prompt and timely diagnosis is a crucial step in disease management. This ...
Safety and Efficacy of Atezolizumab in Ovarian Cancer
Safety and Efficacy of Atezolizumab in Ovarian Cancer
Abstract Introduction Although the efficacy of PD-L1 blockade has been evaluated in analyses that combine pharmacologically distinct antibodies, the specific efficacy and safety of...
IDH and 1p19q Diagnosis in Diffuse Glioma from Preoperative MRI Using Artificial Intelligence
IDH and 1p19q Diagnosis in Diffuse Glioma from Preoperative MRI Using Artificial Intelligence
Abstract Background Isocitrate dehydrogenase (IDH) mutation and 1p19q codeletion are important beneficial prognosticators in gl...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract Introduction Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Abstract 7081: Enzyme hyperactivation to target isocitrate dehydrogenase mutations
Abstract 7081: Enzyme hyperactivation to target isocitrate dehydrogenase mutations
Abstract Somatic mutations in isocitrate dehydrogenase (IDH) enzymes are hallmarks of acute myeloid leukemia (AML), glioma, and several other cancers. Mutations i...
Rare dual‐genotype IDH mutant glioma: Review of previously reported cases and two new cases of true “oligoastrocytoma”
Rare dual‐genotype IDH mutant glioma: Review of previously reported cases and two new cases of true “oligoastrocytoma”
In 2016, the World Health Organization (WHO) eliminated “oligoastrocytoma” from the classification of central nervous system (CNS) tumors, in favor of an integrated histologic and ...

Back to Top